This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent. Top assignee: Microsoft Technology Licensing, LLC. Active years: 2026.
Company Filing History:
Years Active: 2026
Title: Innovations in Pharmaceutical Composition by Sharath Kumar Rangappa
Introduction
Sharath Kumar Rangappa is an innovative inventor based in India, known for his contributions to the field of pharmaceuticals. He has developed a unique orally administerable solid pharmaceutical composition aimed at improving the delivery of proteins and peptides. His work focuses on enhancing the pharmacokinetic profiles and efficacy of treatments for diabetes in both dogs and humans.
Latest Patents
Sharath Kumar Rangappa holds a patent for "An Orally Administerable Solid Pharmaceutical Composition And A Process Thereof." This invention relates to advanced pharmaceutical compositions that allow for the oral delivery of proteins, peptides, or their conjugates. The formulation includes a specific range of insulin and fatty acid components, along with suitable polymer excipients to improve solubility and bioavailability. The innovative process of preparing these formulations is also a significant aspect of his patent.
Career Highlights
Sharath Kumar Rangappa is currently associated with Biocon Limited, a leading biopharmaceutical company. His work at Biocon has allowed him to focus on developing groundbreaking pharmaceutical solutions that address critical health issues. Despite having no patents to his name, his research and development efforts contribute significantly to the field.
Collaborations
Sharath has collaborated with notable colleagues such as Anand Khedkar and Ramesh Subramani. These collaborations have fostered a productive environment for innovation and development within the pharmaceutical sector.
Conclusion
Sharath Kumar Rangappa's contributions to pharmaceutical innovations demonstrate his commitment to improving healthcare solutions. His work in developing effective oral delivery systems for diabetes treatment showcases the potential for advancements in the field.